Kotra Industries : Additional Listing Announcement /Subdivision of Shares
August 20, 2020 at 09:07 pm EDT
Share
Additional Listing Announcement /Subdivision of Shares
1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
Employees' Share Option Scheme
No. of shares issued under this corporate proposal
1,990,000
Issue price per share ($$)
Malaysian Ringgit (MYR) 0.6500
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units
147,526,283
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 77,329,525.500
Listing Date
21 Aug 2020
2. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
Employees' Share Option Scheme
No. of shares issued under this corporate proposal
86,715
Issue price per share ($$)
Malaysian Ringgit (MYR) 1.4000
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units
147,612,998
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 77,450,926.500
Listing Date
21 Aug 2020
Announcement Info
Company Name
KOTRA INDUSTRIES BERHAD
Stock Name
KOTRA
Date Announced
19 Aug 2020
Category
Additional Listing Announcement /Subdivision of Shares
Reference Number
ALA-18082020-00019
Attachments
Original document
Permalink
Disclaimer
Kotra Industries Bhd published this content on 19 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 August 2020 01:07:15 UTC
Kotra Industries Berhad is a Malaysia-based company engaged in investment holding and the provision of management services. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd., is engaged in developing, manufacturing and supplying pharmaceutical and healthcare products. The Company offers a range of healthcare products of over-the-counter (OTC) supplements, nutritional products as well as pharmaceutical products in various dosage forms. The Company's three main brands include Appeton, Axcel, and Vaxcel. The Appeton brand offers high OTC products that cater to all stages of life, from prenatal development needs to geriatric health supplements. Axcel specializes in pediatric care, anti-infective medicine and dermatological care, while Vaxcel products focus on sterile injectables that feature a range of antibiotics to treat an extensive range of health conditions. The Companyâs metered dose inhalers are branded as Arite. Its other brands include Creobic, Minox, and AxPain.